alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Via Email: Lee.Brian@epamail.epa.gov

Brian J. Lee, Ph.D.

New Chemicals Management Branch

Chemical Control Division

US Environmental Protection Agency

New Chemicals Program (7405M)

1200 Pennsylvania Avenue, NW

Washington, DC 20460

June 16, 2011

Re: Application to Exempt New Microorganism [TSCA §5(h)(4)] – Trichoderma reesei 

Dear Dr. Lee:

Please find below proposed language for incorporation into the Trichoderma reesei (“T. reesei”) 

draft rulemaking. As an initial matter, the Enzyme Technical Association (“ETA”) would like to 

reemphasize the long, well-documented safety record of products from T. reesei used in food and 

industrial applications. While ETA recognizes that there are some rather limited studies that 

have successfully induced paracelsin production where T. reesei were stressed and/or exposed to 

certain types of potential triggers, we are not aware of any paracelsin production under standard 

industrial fermentation conditions. 

ETA provides below draft language that we believe should address the Environmental Protection 

Agency’s (“EPA”) concerns about paracelsin production in industrial fermentations involving 

conversion of cellulosic biomass to ethanol. Briefly, the proposed language will ensure that T. 

reesei has been inactivated as per 40 CFR 725.422(d) prior to use in any fermentation that would 

involve the use of plant material for producing ethanol and other biofuels. Under this additional 

limitation, there is no evidence for concern regarding the production of paracelsin. 

By way of ETA’s previous submissions to the agency, and per the EPA’s letter dated May 11, 

2011, standard industrial fermentations using T. reesei have a long and proven safety record. 

We provide two versions of the draft language; however, the only substantive difference is 

format for ease of use by EPA. 
Brian J. Lee, Ph.D.

June 16, 2011

Page 2

Proposed Language

T. reesei will be eligible for Tiered Exemption with the following limitations:

(1) T. reesei microorganisms will only be used under standard industrial fermentation 

conditions, followed by inactivation of the microorganisms as per 40 CFR 725.422(d), 

(2) any fermentation of plant material for producing ethanol and other biofuels, to which 

T. reesei fermentation broth is added, may only be initiated after the inactivation of T. 

reesei as delineated in 40 CFR 725.422(d). 

or, alternatively: 

Any fermentation of plant material for producing ethanol and other biofuels, to which T. 

reesei fermentation broth is added, may only be initiated after the inactivation of T. reesei

as delineated in 40 CFR 725.422(d).

We believe the above language should fully address EPA’s concerns. If you have any questions, 

please do not hesitate to contact us. 

Thank you again for your ongoing support and help with this application process, it is greatly 

appreciated. 

Sincerely, 

Tony Pavel 

ETA 

Cc: Greg Schweer
EXHIBIT 32.2



SECTION 1350 CERTIFICATION

BY CHIEF FINANCIAL OFFICER



I, James F. Verhey, Chief Financial Officer of Kaiser Ventures LLC (the Company), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:



1.
The amended Quarterly Report on Form 10-Q/A of the Company for the quarterly period ended June 30, 2001 (the Report), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m);
and



2. The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.



|                       |  |                               
|---------------------- |  | ------------------------------
|Date: December 2, 2004 |  | /s/ James F. Verhey           
|                       |  | James F. Verhey               
|                       |  | Executive Vice President & CFO



A signed original of
this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 74, Number 184 (Thursday, September 24, 2009)]
[Notices]
[Page 48760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23121]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel. ``NIAID Science Education Awards.''
    Date: October 5, 2009.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Jay Bruce Sundstrom, PhD, Scientific Review 
Official, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217, 
6700B Rockledge Drvie, MSC-7616, Bethesda, MD 20892-7616, (301) 496-
2550, <a href="/cdn-cgi/l/email-protection#aedddbc0cadddadcc1c3c4eec0c7cfc7ca80c0c7c680c9c1d8"><span class="__cf_email__" data-cfemail="added8c3c9ded9dfc2c0c7edc3c4ccc4c983c3c4c583cac2db">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23121 Filed 9-23-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
|  |  |  |
|--|--|--|

----

May 1998

U.S. planting seed exports duringJuly 1997-March 1998 totaled 692,355 metric tons valued at $742.7million, a decrease of 23 percent in volume but an increase of 1percent in value over the same period in 1996/97. Imports for theperiod totaled 142,687 tons (about 4 percent above a year ago)valued at $262.5 million (10 percent above last year).

 

Read the full report in Adobe PDFformat

Planting Seed Exports July-March inAdobe PDF Format

Planting Seed Imports July-March inAdobe PDF Format

|  | Get        the Adobe Acrobat Reader |
|--|-------------------------------------|

Download the trade tables in Lotus123 version 4 format. Please note that some versions of NetscapeNavigator will change the filename extension; if this happens,you MUST rename the file to ffvs04.wk4 to access it.

Contact the author, LoydCoonrod.

 

|                                            |
|-------------------------------------------------|
| *Last modified: Thursday, July 09, 1998*
  |
#### § 1.505 Genealogy.

Information of a genealogical nature when its disclosure will not be detrimental to the memory of the veteran and not prejudicial, so far as may be apparent, to the interests of any living person or to the interests of the Government may be released by the Department of Veterans Affairs or in the case of inactive records may be released by the Archivist of the United States if in the Archivist's custody.

[13 FR 6999, Nov. 27, 1948]
[Federal Register Volume 74, Number 185 (Friday, September 25, 2009)]
[Notices]
[Pages 48970-48971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23133]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Notice of Proposals to Engage in Permissible Nonbanking 
Activities or to Acquire Companies that are Engaged in Permissible 
Nonbanking Activities

    The companies listed in this notice have given notice under section 
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and 
Regulation Y (12 CFR Part 225) to engage de novo, or to acquire or 
control voting securities or assets of a company, including the 
companies listed below, that engages either directly or through a 
subsidiary or

[[Page 48971]]

other company, in a nonbanking activity that is listed in 
Sec. [thinsp]225.28 of Regulation Y (12 CFR 225.28) or that the Board 
has determined by Order to be closely related to banking and 
permissible for bank holding companies. Unless otherwise noted, these 
activities will be conducted throughout the United States.
    Each notice is available for inspection at the Federal Reserve Bank 
indicated. The notice also will be available for inspection at the 
offices of the Board of Governors. Interested persons may express their 
views in writing on the question whether the proposal complies with the 
standards of section 4 of the BHC Act. Additional information on all 
bank holding companies may be obtained from the National Information 
Center website at www.ffiec.gov/nic/.
    Unless otherwise noted, comments regarding the applications must be 
received at the Reserve Bank indicated or the offices of the Board of 
Governors not later than October 9, 2009.
    A. Federal Reserve Bank of New York (Ivan Hurwitz, Bank 
Applications Officer) 33 Liberty Street, New York, New York 10045-0001:
    1. Ladder Capital Finance Holdings LLC, and Ladder Midco LLC, both 
of New York, New York; to engage in commercial real estate finance or 
commercial mortgage backed securities or swaps to hedge risks or 
related advisory, management or servicing activities, pursuant to 
sections 225.28(b)(1), (b)(2)(iv); (b)(7)(i) and (iii); (b)(8)(ii)(B) 
and (ii)(C), of Regulation Y.

    Board of Governors of the Federal Reserve System, September 21, 
2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9-23133 Filed 9-24-09; 8:45 am]
BILLING CODE 6210-01-S
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 21-0479

STATE OF MONTANA,

Plaintiff and Appellee,

v.

DANIEL M. ALLEN,

Defendant and Appellant.

GRANT

Pursuant to authority granted under Mont. R. App. P. 26(1), the 

Appellant is given an extension of time until March 17, 2023, to 

prepare, file, and serve the Appellant’s reply brief.

No further extensions will be granted.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

February 24 2023

02/24/2023

Case Number: DA 21-0479
40878.

#### PHOENIX ASSURANCE COMPANY et al. v. EDWARDS.

Felton, Chief Judge.

In this case the employee was found to be totally disabled and he was awarded compensation “at the rate of $27.60 per week commencing on April 20, 1962, and continuing until there has been a change of condition or until such time as claimant returns to work, etc.” Before the hearing the employee had been offered another job by the employer which he was physically unable to perform. At the hearing it was stated by the attorney for -the employer that other light work would be tendered the employee which he could perform and the employee asserted his willingness to accept such employment when tendered. Such employment has not yet been tendered insofar as the record shows. The only contention made by the employer and insurance carrier is that the bearing deputy director did not contemplate rendering an award in view of the proposed tender of other employment but intended to postpone the hearing to determine whether the additional employment wrould be offered, whether the employee accepted it or whether it was refused without justification. The deputy director resigned before writing the award and the chairman of the board rendered the award which was appealed to the full board and to the superior court, the award, of course being affirmed in every instance. We sec no benefit to be derived from reversing the superior court, and consequently the board, for the reason that if we did and a complete new hearing was had the employee would be entitled to the compensation awarded until he returned to work at the same or higher wage, or to lesser compensation if re-employed at a lesser wage, and compensation would end entirely if the *379employee was tendered work which he was able to do and he refused to accept and perform it without justification. It will serve the same purpose to interpret the award rendered to mean also that compensation will cease as of the time the employee was tendered the less strenuous work contemplated by the parties and he refused to perform it without justification. In any event a new hearing must be called to determine whether compensation be continued as awarded or reduced or stopped, depending upon the facts appearing. There was no harmful error in the judgments of the board or the superior court.

Decided September 29, 1964.

*Smith, Ring el, Martin, Ansley & Carr, Wüliston C. White,*for plaintiffs in error.

*Howe & Murphy, Harold L. Murphy,*contra.

*Judgment affirmed.*

*Frankum and Pannell, JJ., concur.*
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           2,795
<SECURITIES>                                         0
<RECEIVABLES>                                    6,314
<ALLOWANCES>                                       417
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 9,540
<PP&E>                                           9,965
<DEPRECIATION>                                   8,745
<TOTAL-ASSETS>                                  13,872
<CURRENT-LIABILITIES>                            6,119
<BONDS>                                          1,600
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          1
<COMMON>                                            15
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    13,872
<SALES>                                          1,581
<TOTAL-REVENUES>                                 5,650
<CGS>                                              344
<TOTAL-COSTS>                                    7,707
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  40
<INCOME-PRETAX>                                (2,075)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,075)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,075)
<EPS-PRIMARY>                                   (0.15)
<EPS-DILUTED>                                   (0.15)
        

</TABLE>
§ 93.316 Completing the research misconduct process. ( a ) ORI expects institutions to carry inquiries and investigations through to completion and to pursue diligently all significant issues. An institution must notify ORI in advance if the institution plans to close a case at the inquiry, investigation, or appeal stage on the basis that the respondent has admitted guilt, a settlement with the respondent has been reached, or for any other reason, except the closing of a case at the inquiry stage on the basis that an investigation is not warranted or a finding of no misconduct at the investigation stage, which must be reported to ORI under § 93.315.
( b ) After consulting with the institution on its basis for closing a case under paragraph (a) of this section, ORI may conduct an oversight review of the institution's handling of the case and take appropriate action including: ( 1 ) Approving or conditionally approving closure of the case;
( 2 ) Directing the institution to complete its process;
( 3 ) Referring the matter for further investigation by HHS; or,
( 4 ) Taking a compliance action.
- Office Home
- About Us
- Leadership
- Remarks and Releases
- Key Topics
- Reports
- Contact Us
- Public Meetings

HomeU.S. Advisory Commission on Public Diplomacy...Reports – U.S. Advisory Commission on Public Diplomacy

# 						Reports – U.S. Advisory Commission on Public Diplomacy					

							The President, Secretary of State, the Congress, and the American public merit informed, serious, and timely appraisals and recommendations of government activities that intend to understand, inform, and influence global audiences. The ACPD will provide frequent and in-depth information to better serve and empower those that formulate, authorize, fund, and engage in these activities.						

134 items
Clear All Filters

## View collection by:

Select a Year2024202320222021202020192018201720162015201420132011201020082005200420032002200019981996199519931992199119901989198819871986198519831982198019781977197619751974197319711970196919681967196619651964196319621961196019591958195719561955195419531952195119501949

Select a MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember

Select a Release TypeACPD Annual ReportACPD Special Report

Select a Bureau/OfficeU.S. Advisory Commission on Public Diplomacy

          -    ACPD Annual Report  		2005 Annual Report	  November 7, 2005 
          -    ACPD Special Report  		Cultural Diplomacy: The Linchpin of Public Diplomacy (2005)	  September 1, 2005 
          -    ACPD Annual Report  		2004 Annual Report	  September 28, 2004 
          -    ACPD Special Report  		Changing Minds, Winning Peace: A New Strategic Direction for U.S. Public Diplomacy in the Arab & Muslim World (2003)	  October 1, 2003 
          -    ACPD Special Report  		The New Diplomacy: Utilizing Innovative Communication Concepts that Recognize Resource Constraints (2003)	  July 1, 2003 
          -    ACPD Annual Report  		2003 Annual Activity Report	  January 16, 2003 
          -    ACPD Special Report  		Building America’s Public Diplomacy Through a Reformed Structure and Additional Resources (2002)	  July 1, 2002 
          -    ACPD Special Report  		Consolidation of USIA Into The State Department: An Assessment After One Year (2000)	  October 1, 2000 
          -    ACPD Special Report  		Publics and Diplomats in the Global Communications Age (1998)	  October 1, 1998 
          -    ACPD Special Report  		A New Diplomacy for the Information Age (1996)	  November 1, 1996 

previous page123456…14next page

Back to Top
HomeOffice of the SpokespersonPublic Schedule...Public Schedule – February 19, 2023

# 									Public Schedule – February 19, 2023							

Public Schedule

Office of the Spokesperson

February 19, 2023

*****THE DAILY PUBLIC SCHEDULE IS SUBJECT TO CHANGE*****

**SECRETARY ANTONY J. BLINKEN******

Secretary Blinken is on travel to Germany, Türkiye, and Greece from February 16-22, 2023.

**3:30 p.m. LOCAL**Secretary Blinken tours earthquake damage with Turkish Foreign Minister Mevlut Cavusoglu in Hatay Province, Türkiye.**(POOLED PRESS COVERAGE)**

**5:00 p.m. LOCAL**Secretary Blinken tours the Aid Logistics Area at Incirlik Air Force Base,  Türkiye.**(POOLED PRESS COVERAGE/REMARKS AT BOTTOM)**

**6:00 p.m. LOCAL**Secretary Blinken meets with Turkish Military Families affected by the  earthquake, at Incirlik Air Force Base, Türkiye.**(CLOSED PRESS COVERAGE)**

**6:20 p.m. LOCAL**Secretary Blinken meets with DART Search and Rescue Team at Incirlik Air  Force Base, Türkiye.**(POOLED CAMERA SPRAY AT TOP)**

**6:40 p.m. LOCAL**Secretary Blinken meets with White Helmets at Incirlik Air Force Base, Türkiye.

Tags

Earthquakes in Syria and Turkey (Türkiye)Office of the SpokespersonSecretary TripThe Secretary of State

Back to Top
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT

________________________ No. 18

- 15004 Non

- Argument Calendar

________________________ D.C. Docket No. 3:11

- cr - 00030

- LC

- CJK

- 1

UNITED STATES OF AMERICA, Plaintiff

- Appellee,

versus THOMAS STACEY MCDONALD, Defendant

- Appellant.

________________________ Appeal from the United States District Court for the N orthern District of Florida

________________________ (April 10 , 2019) Before ED CARNES , Chief Judge, JILL PRYOR and ANDERSON , Circuit Judges.
PER CURIAM:

Case: 18-15004 Date Filed: 04/10/2019 Page: 1 of 22 Megan Saillant , appointed counsel for Thomas McDonald in this direct criminal appeal, has moved to withdraw from furt her representation of the appellant and filed a brief pursuant to Anders v. California , 386 U.S. 738 (1967). Our independent review of the entire record reveals that counsel’s assessment of the relative merit of the appeal is correct. Because independent examination of the entire record reveals no arguable issues of merit, counsel’s motion to withdraw is GRANTED , and the revocation of McDonald’s supervised release and his
sentence are AFFIRMED

.

Case: 18-15004 Date Filed: 04/10/2019 Page: 2 of 2
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-21-00417-CV

James Construction Group, LLC, Appellant

v.

Ola Pennington, Individually and as Representative of the Estate of Markeith Stokes, 

Deceased; Markeith Pleasant; Micha Pleasant; Malik Pleasant; Malcolm Stokes; and 

Andrew Stokes, Appellees

FROM THE 146TH DISTRICT COURT OF BELL COUNTY

NO. 292,807-B, THE HONORABLE JACK WELDON JONES, JUDGE PRESIDING

M E M O R A N D U M O P I N I O N

Appellant James Construction Group, LLC has filed an unopposed motion 

to dismiss this appeal. We grant appellant’s motion and dismiss the appeal. See Tex. R. App. 

P. 42.1(a).

__________________________________________

Melissa Goodwin, Justice

Before Justices Goodwin, Baker, and Smith

Dismissed on Appellant’s Motion

Filed: September 2, 2021
**EXHIBIT 99.1**

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIALOFFICER PURSUANT TO §906 OF THE SARBANES-OXLEY ACT OF 2002

 

In accordance with 18 U.S.C.1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, theundersigned, in his capacity as the Chief Executive Officer and PrincipalFinancial Officer of 4-D Neuroimaging (the “Company”) hereby certifies, to thebest of his knowledge on the date hereof, that the quarterly report on Form10-QSB for the quarter ended March 31, 2003 (the “Form 10-QSB”), filedconcurrently herewith by the Company, fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, andthat the information contained in the Form 10-QSB fairly presents, in allmaterial respects, the Company’s financial condition at the end of such quarterand the Company’s results of operations for such quarter.

 

 
| /s/  D. Scott Buchanan                              |   |
|----------------------------------------------------------|--------|
| D. Scott  Buchanan                                       |
| Chief  Executive Officer and Principal Financial Officer |
|                                                     |
| Dated:  May 13, 2003                                |

 

----
Docket Number FAA-2013-0669